[HTML][HTML] COX-2 as a potential biomarker and therapeutic target in melanoma
With a constantly increasing incidence, cutaneous melanoma has raised the need for a
better understanding of its complex microenvironment that may further guide therapeutic …
better understanding of its complex microenvironment that may further guide therapeutic …
[HTML][HTML] Differential expression of cyclooxygenase-2 in metastatic melanoma affects progression free survival
E Panza, P De Cicco, G Ercolano, C Armogida… - Oncotarget, 2016 - ncbi.nlm.nih.gov
The possible correlation between cyclooxygenase-2 (COX-2) expression and disease
progression in melanoma is still a matter of debate. Analysis of COX-2 expression in 45 …
progression in melanoma is still a matter of debate. Analysis of COX-2 expression in 45 …
Analysis of cyclooxygenase 2 (COX-2) expression during malignant melanoma progression
AC Goulet, JG Einsphar, DS Alberts, A Beas… - Cancer biology & …, 2003 - Taylor & Francis
Cyclooxygenase 2 (COX-2) is an inducible enzyme involved in the production of
prostaglandins and thromboxanes during inflammation. There are now several lines of …
prostaglandins and thromboxanes during inflammation. There are now several lines of …
Synergistic inhibitory effects of Celecoxib and Plumbagin on melanoma tumor growth
R Gowda, A Sharma, GP Robertson - Cancer letters, 2017 - Elsevier
Melanoma is a highly drug resistant cancer. To circumvent this problem, a class of
synergistically acting drug combinations, which inhibit multiple key pathways in melanoma …
synergistically acting drug combinations, which inhibit multiple key pathways in melanoma …
Celecoxib in cancer therapy and prevention–review
N Tołoczko-Iwaniuk… - Current Drug …, 2019 - ingentaconnect.com
Background and Objectives: It is generally accepted that inflammatory cells found in the
tumor microenvironment are involved in the neoplastic process, promoting cell proliferation …
tumor microenvironment are involved in the neoplastic process, promoting cell proliferation …
Celecoxib: a specific COX-2 inhibitor with anticancer properties
AT Koki, JL Masferrer - Cancer control, 2002 - journals.sagepub.com
In addition to the well-established pathophysiological role that COX-2 plays in inflammation,
recent evidence implies that this isoform may also be involved in multiple biologic events …
recent evidence implies that this isoform may also be involved in multiple biologic events …
Cyclooxygenase 2 (COX2) and peroxisome proliferator-activated receptor gamma (PPARG) are stage-dependent prognostic markers of malignant melanoma
S Meyer, T Vogt, M Landthaler, A Berand… - From Molecular to …, 2010 - Springer
COX2 and PPARG are differentially expressed in many human tumors and have emerged
as potential targets of biomodulatory cancer therapy. Using three tissue microarrays (TMA) …
as potential targets of biomodulatory cancer therapy. Using three tissue microarrays (TMA) …
Influencing COX-2 activity by COX related pathways in inflammation and cancer
T Yu, X Lao, H Zheng - Mini reviews in medicinal chemistry, 2016 - ingentaconnect.com
Cancer is a major cause of death worldwide despite significant advances in surgery and
biology. Several recent studies have suggested that there is a close connection between …
biology. Several recent studies have suggested that there is a close connection between …
Expression of cyclooxygenase-2 in benign naevi and during human cutaneous melanoma progression
L Kuzbicki, A Sarnecka, BW Chwirot - Melanoma research, 2006 - journals.lww.com
Abstract Cyclooxygenase-2 (COX-2) is an enzyme that plays an important role in the
production of prostaglandins. Numerous studies have demonstrated increased levels of …
production of prostaglandins. Numerous studies have demonstrated increased levels of …
Biology of Cox-2: an application in cancer therapeutics
Z Khan, N Khan, RP Tiwari, NK Sah… - Current drug …, 2011 - ingentaconnect.com
Cyclooxygenase-2 (Cox-2) is an inducible enzyme involved in the conversion of arachidonic
acid to prostaglandin and other eicosanoids. Molecular pathology studies have revealed …
acid to prostaglandin and other eicosanoids. Molecular pathology studies have revealed …